These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 29294212)
1. Chitosan Engineered PAMAM Dendrimers as Nanoconstructs for the Enhanced Anti-Cancer Potential and Improved In vivo Brain Pharmacokinetics of Temozolomide. Sharma AK; Gupta L; Sahu H; Qayum A; Singh SK; Nakhate KT; Ajazuddin ; Gupta U Pharm Res; 2018 Jan; 35(1):9. PubMed ID: 29294212 [TBL] [Abstract][Full Text] [Related]
2. Angiopep-2 Grafted PAMAM Dendrimers for the Targeted Delivery of Temozolomide: Sahoo RK; Kumar H; Jain V; Sinha S; Ajazuddin ; Gupta U ACS Biomater Sci Eng; 2023 Jul; 9(7):4288-4301. PubMed ID: 37307155 [TBL] [Abstract][Full Text] [Related]
3. Dendrimer encapsulated and conjugated delivery of berberine: A novel approach mitigating toxicity and improving in vivo pharmacokinetics. Gupta L; Sharma AK; Gothwal A; Khan MS; Khinchi MP; Qayum A; Singh SK; Gupta U Int J Pharm; 2017 Aug; 528(1-2):88-99. PubMed ID: 28533175 [TBL] [Abstract][Full Text] [Related]
4. Formulation of temozolomide-loaded nanoparticles and their targeting potential to melanoma cells. Jiang G; Li R; Tang J; Ma Y; Hou X; Yang C; Guo W; Xin Y; Liu Y Oncol Rep; 2017 Feb; 37(2):995-1001. PubMed ID: 28035395 [TBL] [Abstract][Full Text] [Related]
5. A novel biocompatible drug delivery system of chitosan/temozolomide nanoparticles loaded PCL-PU nanofibers for sustained delivery of temozolomide. Irani M; Mir Mohamad Sadeghi G; Haririan I Int J Biol Macromol; 2017 Apr; 97():744-751. PubMed ID: 28109815 [TBL] [Abstract][Full Text] [Related]
6. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery. Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851 [TBL] [Abstract][Full Text] [Related]
7. PEGylated Dendrimer Mediated Delivery of Bortezomib: Drug Conjugation versus Encapsulation. Sahoo RK; Gothwal A; Rani S; Nakhate KT; Ajazuddin ; Gupta U Int J Pharm; 2020 Jun; 584():119389. PubMed ID: 32380027 [TBL] [Abstract][Full Text] [Related]
8. A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system. Lu Y; Han S; Zheng H; Ma R; Ping Y; Zou J; Tang H; Zhang Y; Xu X; Li F Int J Nanomedicine; 2018; 13():5937-5952. PubMed ID: 30323584 [TBL] [Abstract][Full Text] [Related]
9. Polyamidoamine dendrimer conjugated chitosan nanoparticles for the delivery of methotrexate. Leng ZH; Zhuang QF; Li YC; He Z; Chen Z; Huang SP; Jia HY; Zhou JW; Liu Y; Du LB Carbohydr Polym; 2013 Oct; 98(1):1173-8. PubMed ID: 23987460 [TBL] [Abstract][Full Text] [Related]
10. A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration. Xu X; Li J; Han S; Tao C; Fang L; Sun Y; Zhu J; Liang Z; Li F Eur J Pharm Sci; 2016 Jun; 88():178-90. PubMed ID: 26965003 [TBL] [Abstract][Full Text] [Related]
11. Bendamustine-PAMAM Conjugates for Improved Apoptosis, Efficacy, and in Vivo Pharmacokinetics: A Sustainable Delivery Tactic. Gothwal A; Khan I; Kumar P; Raza K; Kaul A; Mishra AK; Gupta U Mol Pharm; 2018 Jun; 15(6):2084-2097. PubMed ID: 29195048 [TBL] [Abstract][Full Text] [Related]
12. Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma. Ling Y; Wei K; Zou F; Zhong S Int J Pharm; 2012 Jul; 430(1-2):266-75. PubMed ID: 22486964 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells. Hu J; Wang J; Wang G; Yao Z; Dang X Int J Mol Med; 2016 Mar; 37(3):690-702. PubMed ID: 26782731 [TBL] [Abstract][Full Text] [Related]
14. Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model. Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats TS Cancer Biol Ther; 2009 Oct; 8(20):1924-33. PubMed ID: 19738431 [TBL] [Abstract][Full Text] [Related]
15. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery. Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691 [TBL] [Abstract][Full Text] [Related]
16. Boosted Memory and Improved Brain Bioavailability of Rivastigmine: Targeting Effort to the Brain Using Covalently Tethered Lower Generation PAMAM Dendrimers with Lactoferrin. Gothwal A; Nakhate KT; Alexander A; Ajazuddin ; Gupta U Mol Pharm; 2018 Oct; 15(10):4538-4549. PubMed ID: 30156844 [TBL] [Abstract][Full Text] [Related]
17. Microdialysis measurement of intratumoral temozolomide concentration after cediranib, a pan-VEGF receptor tyrosine kinase inhibitor, in a U87 glioma model. Grossman R; Tyler B; Rudek MA; Kim E; Zadnik P; Khan U; Blakeley JO; Pathak AP; Brem H Cancer Chemother Pharmacol; 2013 Jul; 72(1):93-100. PubMed ID: 23649683 [TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic and therapeutic investigation of focused ultrasound-induced blood-brain barrier opening for enhanced temozolomide delivery in glioma treatment. Liu HL; Huang CY; Chen JY; Wang HY; Chen PY; Wei KC PLoS One; 2014; 9(12):e114311. PubMed ID: 25490097 [TBL] [Abstract][Full Text] [Related]
19. Mustard-inspired delivery shuttle for enhanced blood-brain barrier penetration and effective drug delivery in glioma therapy. Wang N; Sun P; Lv M; Tong G; Jin X; Zhu X Biomater Sci; 2017 May; 5(5):1041-1050. PubMed ID: 28378865 [TBL] [Abstract][Full Text] [Related]
20. Surface-coated PLA nanoparticles loaded with temozolomide for improved brain deposition and potential treatment of gliomas: development, characterization and in vivo studies. Jain D; Bajaj A; Athawale R; Shrikhande S; Goel PN; Nikam Y; Gude R; Patil S; Prashant Raut P Drug Deliv; 2016; 23(3):999-1016. PubMed ID: 25026415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]